Related Experiment Video
Updated: Jun 12, 2026

Analysis of Interactions between Endobiotics and Human Gut Microbiota Using In Vitro Bath Fermentation Systems
Published on: August 23, 2019
Structural profiles and prebiotic functions of bifidobacterial exopolysaccharides revealed by a polysaccharide-free
Nanyu Tang1, Qiaoya Mo1, Chang Xu2
1Sanya Institute of Nanjing Agricultural University, College of Food Science and Technology, Nanjing Agricultural University, Nanjing, Jiangsu, 210095, PR China.
Insights
Bifidobacterium exopolysaccharides (EPS) from infant strains selectively promote beneficial gut bacteria and increase short-chain fatty acids (SCFAs). These findings highlight the prebiotic potential of Bifidobacterium EPS for targeted gut health modulation.
Area of Science:
- Microbiology
- Gut Microbiome Research
- Nutritional Science
Background:
- Bifidobacterium exopolysaccharides (EPS) are recognized for their potential gut health benefits.
- The specific impact of Bifidobacterium EPS on gut microbiota composition and function requires further elucidation.
- Understanding EPS structure-function relationships is key to harnessing their prebiotic potential.
Purpose of the Study:
- To extract and characterize exopolysaccharides (EPS) from infant-derived Bifidobacterium strains.
- To investigate the in vitro prebiotic effects of specific Bifidobacterium EPS on gut microbiota composition and short-chain fatty acid (SCFA) production.
- To elucidate the structure of EPS and correlate it with their observed prebiotic activities.
Main Methods:
- Extraction of EPS from six infant Bifidobacterium strains (B. breve, B. longum subsp. longum) using a specialized MRS-TY medium.
- Structural characterization of EPS, including monosaccharide profiling.
- In vitro growth assays to assess EPS utilization by specific Lactobacillus strains.
- In vitro fermentation of EPS with human fecal cultures to evaluate microbiota modulation and SCFA production.
Main Results:
- EPS from B. breve BB033 (BB-EPS) and B. longum subsp. longum 8216 (BLL-EPS) were successfully extracted and characterized, showing distinct monosaccharide compositions (e.g., high galactose in BB-EPS).
- BB-EPS specifically promoted Lactobacillus crispatus C-3 growth, while BLL-EPS supported a broader range of Lactobacillus strains.
- Both BB-EPS and BLL-EPS selectively enriched beneficial gut bacteria (Bifidobacterium, Blautia) and increased SCFA production, with BB-EPS showing higher efficacy in total SCFA stimulation.
Conclusions:
- Bifidobacterium exopolysaccharides possess distinct structural features that dictate their prebiotic activity.
- Both BB-EPS and BLL-EPS demonstrate significant potential as prebiotics, capable of modulating gut microbiota composition and enhancing SCFA production.
- These findings provide a scientific basis for utilizing specific Bifidobacterium EPS as targeted functional ingredients for improving gut health.
Abstract:
Bifidobacterium exopolysaccharides (EPS) are recognized as key effector molecules with potential benefits for gut health, yet the specific impact on the gut microbiota remains to be elucidated. In this study, EPS were extracted from six infant-derived Bifidobacterium strains (three B. breve and three B. longum subsp. longum) using a non-interfering culture medium (MRS-TY) designed to eliminate exogenous polysaccharides. Structural characterization confirmed that the MRS-TY medium enabled the acquisition of authentic EPS, revealing distinct monosaccharide profiles. In vitro growth assays demonstrated the EPS from B. breve BB033 (BB-EPS) specifically promoted Lactobacillus crispatus C-3, whereas the EPS from B. longum subsp. longum 8216 (BLL-EPS) was broadly utilized by several Lactobacillus strains. BB-EPS was characterized by a high galactose content (50.93%), alongside glucose (13.81%) and mannose (20.62%), whereas BLL-EPS exhibited a combined glucose-galactose profile, with galactose (54.48%) and glucose (27.41%) as the predominant components. The prebiotic potential of BB-EPS and BLL-EPS was further evaluated through in vitro fermentation with fecal cultures. Both EPS selectively modulated the gut microbiota, enriching beneficial genera including Bifidobacterium, Blautia, and unclassified_f__Ruminococcaceae, while significantly increasing the production of short-chain fatty acids (SCFAs), particularly acetic and propionic acid. Notably, BB-EPS demonstrated a greater capacity to stimulate total SCFAs production. This study elucidates the prebiotic activities of bifidobacterial EPS and provides a foundation for their application as targeted modulators of gut health.
Related Concept Videos
Biosynthesis of Polysaccharides
Biofilms
Formation of Lipopolysaccharides
Bioplastics
Bacterial Phylum Firmicutes
Outer Layers of the Cell Envelope

